SDSubhajit Dutta

Subhajit Dutta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Subhajit Dutta has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Advanced Targeted Drug Delivery Systems for Several Health Issues Using Nanotechnology

    by Subhajit Dutta, Shanmugam Ramaswamy, G. Mirunalini, Shruthi Bejjanki, Parikshit Roychowdhury, S. Hemachandra

    Despite its advances in medicine, cancer still remains elusive for most of the conventional therapies because the medications are applied to healthy tissues as well; traditional procedures frequently result in significant adverse effects. This chapter provides a comprehensive overview of the role of nanotechnology in cancer diagnosis, imaging, and treatment. The chapter explores both passive and active targeting techniques as well as the mechanics behind medication delivery using nanoparticles. Therefore, the potential of nanotechnology to improve biomarker detection and cancer imaging is investigated. Furthermore, the prospect of nanotechnology for co-delivery of numerous therapeutic drugs into a single nanocarrier and combination therapy is investigated, emphasising the synergistic benefits and improved therapeutic results possible with this strategy. Overall, this chapter emphasises how much nanotechnology may do to enhance cancer outcomes by offering focused, effective, and least intrusive treatment options.

  • Open Access

    Nanoencapsulation of Rosmarinus officinalis essential oil into Chitosan crosslinked to Tripolyphosphate nanoparticles and Alginate/Chitosan nanoparticles: Formulation, characterization, in vitro release study, and in vivo evaluation

    by Djaafer Hamza Hellali, Nabila Ayachi

    This study delves into the intricate realm of nanoencapsulation, focusing on the application of chitosan crosslinked to TPP and alginate/chitosan-based nanoparticles to encapsulate Rosmarinus officinalis essential oil. The core objective was to unravel the potential pharmacological merits and controlled release dynamics underpinning this novel encapsulation technique. The experimental results painted a compelling portrait of rosemary oil, showcasing its multifaceted efficacy as an antibacterial, antifungal, and antioxidant agent. In the realm of nanotechnology, we were able to formulate nanoparticles under 100 nm, demonstrating exceptional stability. A pivotal aspect of this research revolved around encapsulation efficiency, determined via UV-vis spectroscopy. The results proved staggering, illustrating an encapsulation rate surpassing the 98% benchmark, ensuring minimal essential oil wastage. In vitro assays illuminated the controlled, sustained release attributes of the encapsulated essential oil, thereby further substantiating the potential of this encapsulation approach. FTIR analysis provided insights into the intricate interactions transpiring within these nanoparticles. Venturing into living organisms, our comprehensive in vivo assessments confirmed the significant analgesic activity of our nanoparticles encapsulating rosemary essential oil. This revelation opens exciting prospects for therapeutic applications. Microscopic observations into the SEM solidified the presence and even distribution of these nanoparticles. These compelling findings chart new avenues for the development of more potent, precisely targeted pharmaceutical interventions. Keywords: Rosemary essential oil, chitosan, sodium alginate, polymeric nanoparticles, nanoencapsulation


  • Open Access

    The ethanol extract of Muntingia calabura exhibits in vitro antidiabetic potentials by inhibiting carbohydrate digestive enzymes

    by Subhajit Dutta, C Ramesh, A Madhu, Krishna Pundi, B.A. Sowmya

    Objective: The present research study was conducted to investigate in vitro anti-diabetic potentials of ethanol extract of leaves of Muntingia calabura for α-glucosidase and α-amylase inhibitory activities. Materials & Methods: The leaves of Muntingia calabura were collected and authenticated. dried and powdered. The powdered drug was defatted using petroleum ether and extracted with ethanol. The ethanol extract of Muntingia calabura was subjected to preliminary phytochemical investigation. The in vitro α-glucosidase inhibitory and α-amylase inhibitory properties were determined for the ethanol extract and concentrations of extract required to inhibit absorbance (IC50 values) EEMC were determined. Results: Significant IC50 values were found in both tests that assessed the inhibitory activity of α-glucosidase and α-amylase, demonstrating the capacity of the ethanol extract of Muntingia calabura to block carbohydrate digesting enzymes and prevent postprandial blood glucose. Conclusion: The results of the presents investigation recommends that ethanol extract of Muntingia calabura possess significant α-glucosidase and α-amylase inhibitory activity. Keywords: Antidiabetic activity, Muntingia calabura, α-glucosidase and α-amylase and IC50values.